Related Experiment Video

Updated: May 20, 2026

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

[Severe meprobamate poisoning: description of 146 cases in a French department]

Bérenger Mounier1, Bertrand Pons, Xavier Delavenne

  • 1Urgences Médico-chirurgicales, Hôpital Nord, CHU, Saint-Étienne, France.

Therapie
|August 2, 2012
PubMed

Insights

Severe meprobamate poisoning, even with aceprometazine, presents serious ICU admission criteria. This study found no significant differences in severity, supporting the cessation of marketing meprobamate-based drugs.

Area of Science:

  • Toxicology
  • Pharmacology
  • Critical Care Medicine

Context:

  • Meprobamate poisoning poses significant health risks, with potential market withdrawal implications.
  • A multicenter retrospective study was conducted to evaluate severe poisoning cases.
  • The study included patients admitted to the Intensive Care Unit (ICU) for meprobamate poisoning, both alone and in combination with aceprometazine.

Purpose:

  • To assess the clinical and biological severity criteria of patients admitted to the ICU for severe meprobamate poisoning.
  • To compare severity between meprobamate alone and meprobamate-aceprometazine combination poisonings.
  • To inform decisions regarding the marketing status of meprobamate-based specialities.

Summary:

  • 146 patients were enrolled between 2005 and 2011.
  • 88% presented with coma (Glasgow ≤ 7) and 50% had systolic blood pressure ≤ 90 mmHg upon admission.
  • A 3% mortality rate was observed, with no significant differences in severity criteria between the groups.

Impact:

  • The findings suggest that meprobamate poisoning, regardless of combination with aceprometazine, presents similar severe clinical and biological criteria.
  • The study's results provide evidence to support the cessation of marketing for all meprobamate-based specialities.
  • This research contributes to patient safety by highlighting the risks associated with meprobamate and informing regulatory decisions.

More Related Videos

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

Coronary Angiography During Ex-Situ Heart Perfusion in a Porcine Model06:25

Coronary Angiography During Ex-Situ Heart Perfusion in a Porcine Model

Published on: July 12, 2024

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...